DPLS Security Details Share Structure Market Value1...........$802,228 a/o Oct 21, 2020 Authorized Shares..20,000,000,000 a/o Oct 20, 2020 Outstanding Shares..4,011,139,156 a/o Oct 20, 2020 Restricted...............31,894,998 a/o Oct 20, 2020 Unrestricted..........3,979,244,158 a/o Oct 20, 2020 Held at DTC...............Not Available Float.....................Not Available Par Value 0.01
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.